Real-time MR guides liver cryotherapy
Interventional radiologists can now see liver tumors freeze in real-time on MR imaging as they perform thermal ablation, according to a study presented at the 2004 RSNA meeting.
Interventional radiologists can now see liver tumors freeze in real-time on MR imaging as they perform thermal ablation, according to a study presented at the 2004 RSNA meeting.
Dr. Kemal Tuncali and colleagues at Brigham and Women's Hospital used MR-guided cryotherapy to treat 44 liver tumors in 31 patients. They ablated 19 tumors, 17 of which required only one treatment. Six of the failed treatments showed residual tumor at 24-hour imaging, and 14 showed recurrence during follow-up (mean time 13 months).
The researchers recorded four complications from a total of 51 cryoablations. Seven patients died during follow-up, two due to systemic progression. The overall survival rate was 76%.
Monitoring is critical in this type of procedure, which holds an advantage over other minimally invasive techniques in which direct visualization is not possible, Tuncali said.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
